Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01071096 · ClinicalTrials.gov registry record · Phase 4

Calcitonin Gene-related Peptide Levels in Chronic Migraine

A Phase 4 study of Chronic Migraine, sponsored by Cady, Roger, M.D..

Completed
Registry status
Phase 4
Development phase
20
Enrollment target
2
Study locations

NCT01071096 is a Phase 4 study of Chronic Migraine that has completed, run by Cady, Roger, M.D.. The registered enrollment target is 20 participants, below the 342-participant average among 17 other Chronic Migraine trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01071096, a Phase 4 study of Chronic Migraine, has completed, sponsored by Cady, Roger, M.D..

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

Twenty patients will be enrolled in a 2-site, 7-month, double-blind study conducted to evaluate a reduction in headache days and attacks and calcitonin gene-related peptide (CGRP) levels in saliva following treatment with OnabotulinumtoxinA versus saline. Eligible patients will be randomized and receive injections of OnabotulinumtoxinA or Saline at Visit 1. Following 3 months plus a 1 month wash out, patients will receive cross-over injections at Visit 5. Patients will return for monthly visits and exit the study at Visit 8. Patients will collect saliva at monthly intervals and document in a daily headache diary throughout the study .

Conditions Studied

Chronic Migraine

Interventions

  • DRUG Saline
  • DRUG OnabotulinumtoxinA

Study Locations (2)

Missouri

  • Clinvest - Springfield

New York

  • Island Neurological Associates, P.C. - Plainview

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-06
Est. Completion 2011-06
Phase Phase 4

Sponsor

Cady, Roger, M.D.

12 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01071096

The ClinicalTrials.gov registry entry for NCT01071096 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 342-participant average among 17 other Chronic Migraine trials with a reported enrollment target (94% lower). The listed sponsor is Cady, Roger, M.D., which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Migraine appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT01071096 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, New York.

Frequently Asked Questions

What is clinical trial NCT01071096 about?

NCT01071096 is a clinical study titled "Calcitonin Gene-related Peptide Levels in Chronic Migraine". Twenty patients will be enrolled in a 2-site, 7-month, double-blind study conducted to evaluate a reduction in headache days and attacks and calcitonin gene-related peptide (CGRP) levels in saliva following treatment with OnabotulinumtoxinA versus saline. Eligible patients will be randomized and re...

What is the current status of trial NCT01071096?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-06. Estimated completion is 2011-06.

What conditions does trial NCT01071096 study?

This clinical trial studies the following conditions: Chronic Migraine.

What interventions are being tested in trial NCT01071096?

The interventions under investigation include: Saline (DRUG), OnabotulinumtoxinA (DRUG).

Who is sponsoring clinical trial NCT01071096?

This trial is sponsored by Cady, Roger, M.D., which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01071096 being conducted?

This trial has 2 study locations across Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Migraine

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.